David Hollander
Chief Medical Officer
Research & Development
Oraclinical
United States of America
Biography
Board certified ophthalmologist with significant expertise in regulatory, trial design and endpoint selection; David leads the Ora Institute, the internal R&D group focused on method and model development.
Research Interest
His research interest in opthamology,Trial design and selection.
